CONCORD BIOTECH
Back to Balance Sheet
|
CONCORD BIOTECH Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹2,034 Cr | ₹1,701 Cr | ₹1,514 Cr | ₹1,502 Cr | ₹1,313 Cr |
What is the latest Total Liabilities ratio of CONCORD BIOTECH ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹2,034 Cr |
| Mar2024 | ₹1,701 Cr |
| Mar2023 | ₹1,514 Cr |
| Mar2022 | ₹1,502 Cr |
| Mar2021 | ₹1,313 Cr |
How is Total Liabilities of CONCORD BIOTECH Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,034 Cr | 19.61 | |
| Mar2024 | ₹1,701 Cr | 12.33 | |
| Mar2023 | ₹1,514 Cr | 0.81 | |
| Mar2022 | ₹1,502 Cr | 14.41 | |
| Mar2021 | ₹1,313 Cr | - | |
Compare Total Liabilities of peers of CONCORD BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CONCORD BIOTECH | ₹11,839.7 Cr | 7.7% | 8.9% | -35.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,830.0 Cr | 5.9% | -0.9% | -3.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹173,484.0 Cr | 2.5% | 8.7% | 3.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹143,166.0 Cr | 2% | -1.6% | 25.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,018.0 Cr | -0.2% | 2.2% | 12.8% | Stock Analytics | |
| CIPLA | ₹106,357.0 Cr | 0.8% | 5.9% | -15.7% | Stock Analytics | |
CONCORD BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CONCORD BIOTECH | 7.7% |
8.9% |
-35.1% |
| SENSEX | -1.3% |
4.6% |
-3.3% |
You may also like the below Video Courses